ATE321777T1 - Ölkörper und damit assoziierte proteine als affinitätsmatrix - Google Patents

Ölkörper und damit assoziierte proteine als affinitätsmatrix

Info

Publication number
ATE321777T1
ATE321777T1 AT97946991T AT97946991T ATE321777T1 AT E321777 T1 ATE321777 T1 AT E321777T1 AT 97946991 T AT97946991 T AT 97946991T AT 97946991 T AT97946991 T AT 97946991T AT E321777 T1 ATE321777 T1 AT E321777T1
Authority
AT
Austria
Prior art keywords
associated proteins
oil body
affinity matrix
affinity
matrix
Prior art date
Application number
AT97946991T
Other languages
English (en)
Inventor
Maurice Moloney
Joseph Boothe
Rooijen Gijs Van
Original Assignee
Sembiosys Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sembiosys Genetics Inc filed Critical Sembiosys Genetics Inc
Application granted granted Critical
Publication of ATE321777T1 publication Critical patent/ATE321777T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G11/00—Compounds of cadmium
    • C01G11/003—Preparation involving a liquid-liquid extraction, an adsorption or an ion-exchange
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B1/00—Preparatory treatment of cellulose for making derivatives thereof, e.g. pre-treatment, pre-soaking, activation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97946991T 1996-12-16 1997-12-05 Ölkörper und damit assoziierte proteine als affinitätsmatrix ATE321777T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/767,026 US5856452A (en) 1996-12-16 1996-12-16 Oil bodies and associated proteins as affinity matrices

Publications (1)

Publication Number Publication Date
ATE321777T1 true ATE321777T1 (de) 2006-04-15

Family

ID=25078275

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97946991T ATE321777T1 (de) 1996-12-16 1997-12-05 Ölkörper und damit assoziierte proteine als affinitätsmatrix

Country Status (18)

Country Link
US (5) US5856452A (de)
EP (1) EP1007554B1 (de)
JP (2) JP3833719B2 (de)
KR (1) KR100421935B1 (de)
CN (1) CN1325513C (de)
AR (1) AR010780A1 (de)
AT (1) ATE321777T1 (de)
AU (1) AU739339B2 (de)
BR (1) BR9713727B1 (de)
CA (1) CA2275489C (de)
DE (1) DE69735599T2 (de)
DK (1) DK1007554T3 (de)
ES (1) ES2259193T3 (de)
IL (1) IL130403A (de)
NZ (1) NZ336558A (de)
TW (1) TW589322B (de)
WO (1) WO1998027115A1 (de)
ZA (1) ZA9711237B (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices
US7585645B2 (en) 1997-05-27 2009-09-08 Sembiosys Genetics Inc. Thioredoxin and thioredoxin reductase containing oil body based products
US6599513B2 (en) 1997-05-27 2003-07-29 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
US20050106157A1 (en) * 1997-05-27 2005-05-19 Deckers Harm M. Immunogenic formulations comprising oil bodies
DE69839148T2 (de) * 1997-05-27 2009-02-12 SemBioSys Genetics, Inc., Calgary Verwendungen von ölkörpern
AU772919C (en) * 1997-05-27 2004-12-16 Sembiosys Genetics Inc. Uses of oil bodies
US6761914B2 (en) 1997-05-27 2004-07-13 Sembiosys Genetics Inc. Immunogenic formulations comprising oil bodies
MXPA01005276A (es) * 1998-11-25 2002-04-24 Sembiosys Genetics Inc Cuerpos grasos como vehiculos de suministro topico para agentes activos.
AU2001267218C1 (en) * 2000-06-16 2006-07-27 Sembiosys Genetics Inc. The use of plant oil-bodies in vaccine delivery systems
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US7098383B2 (en) * 2000-12-19 2006-08-29 Sembiosys Genetics Inc. Methods for the production of multimeric immunoglobulins, and related compositions
US20030167524A1 (en) * 2000-12-19 2003-09-04 Rooijen Gijs Van Methods for the production of multimeric protein complexes, and related compositions
AU3281902A (en) * 2000-12-19 2002-07-01 Sembiosys Genetics Inc Methods for the production of multimeric proteins, and related compositions
US20060179514A1 (en) * 2001-07-05 2006-08-10 Sembiosys Genetics, Inc. Methods for the production of multimeric protein complexes, and related compositions
EP2305312B1 (de) 2001-10-10 2015-03-04 ratiopharm GmbH Neumodulierung und Glykokonjugation von Follitropin (FSH)
US6806078B2 (en) * 2002-08-27 2004-10-19 William A. Newman Substrate and method for anaerobic remediation
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
AU2003279493B2 (en) * 2002-10-25 2009-08-20 Foamix Pharmaceuticals Ltd. Cosmetic and pharmaceutical foam
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
EP1615945B1 (de) 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylierungsverfahren und durch die verfahren hergestellte proteine/peptide
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
ES2313018T3 (es) * 2003-06-17 2009-03-01 Sembiosys Genetics Inc. Procedimiento de produccion de insulina en plantas.
WO2004113540A1 (en) * 2003-06-18 2004-12-29 The University Of York Expression of heterologous protein
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
CN1856294A (zh) * 2003-08-25 2006-11-01 弗米克斯有限公司 渗透性药物泡沫
AU2004275451B2 (en) * 2003-10-02 2010-11-25 Sembiosys Genetics Inc. Methods for preparing oil bodies comprising active ingredients
MX2007014101A (es) * 2005-05-09 2009-02-13 Foamix Ltd Vehiculo espumable y composiciones farmaceuticas del mismo.
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US7256014B2 (en) * 2005-07-27 2007-08-14 E. I. Du Pont De Nemours And Company Method to increase hydrophobic compound titer in a recombinant microorganism
CA2626390C (en) * 2005-10-19 2018-02-20 Agriculture Victoria Services Pty Ltd Polyoleosins
EP2044207A1 (de) * 2006-07-11 2009-04-08 Basf Se Steuern von proteinen auf lipidkörper als ziel
JP2010502690A (ja) * 2006-09-08 2010-01-28 フォーミックス エルティーディー． 有色または着色可能発泡性組成物
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US20080206155A1 (en) * 2006-11-14 2008-08-28 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20100063257A1 (en) * 2007-01-26 2010-03-11 Merck Serono Sa Purification of FC-TACI Fusion Proteins Using the Oilbody Technology
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2009089115A1 (en) * 2008-01-04 2009-07-16 Hormel Foods Corporation Encapsulation of oxidatively unstable compounds
US20110020519A1 (en) * 2008-01-04 2011-01-27 Aveka, Inc. Encapsulation of oxidatively unstable compounds
EP2242476A2 (de) * 2008-01-14 2010-10-27 Foamix Ltd. Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
US8592555B2 (en) * 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG195555A1 (en) * 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
MX359879B (es) 2009-10-02 2018-10-12 Foamix Pharmaceuticals Ltd Composiciones tópicas de tetraciclina.
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
TWI377954B (en) * 2009-11-25 2012-12-01 Univ China Medical Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein
CN102100914A (zh) * 2010-12-21 2011-06-22 陈顺基 能靶向治疗乳癌的人造油体载体及其制备方法和应用
SG186552A1 (en) 2011-06-08 2013-01-30 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
FI20115704L (fi) 2011-07-01 2013-01-02 Teknologian Tutkimuskeskus Vtt Oy Vierasproteiinien tuoton parantaminen
US20140220217A1 (en) 2011-07-12 2014-08-07 Maraxi, Inc. Method and compositions for consumables
PL2731451T3 (pl) 2011-07-12 2019-03-29 Impossible Foods Inc. Sposoby i kompozycje dla produktów żywnościowych
JP6650671B2 (ja) 2011-07-12 2020-02-19 インポッシブル フーズ インコーポレイテッド 摂食可能品のための方法および組成物
US10039306B2 (en) 2012-03-16 2018-08-07 Impossible Foods Inc. Methods and compositions for consumables
CA2897600C (en) 2013-01-11 2023-10-17 Impossible Foods Inc. Methods and compositions for affecting the flavor and aroma profile of consumables
MX369359B (es) 2013-01-11 2019-11-06 Impossible Foods Inc Replica no lactea de queso ricotta.
KR102669270B1 (ko) 2014-03-31 2024-05-27 임파서블 푸즈 인크. 재조합 효모
HRP20201333T1 (hr) * 2015-10-15 2020-11-27 Cargill, Incorporated Kompozicija koja sadrži oleosome sa različitom raspodjelom veličina
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US20200131553A1 (en) * 2016-10-03 2020-04-30 Alcantara Research Group Inc. A chloroplast or accumulated lipid particle enriched with an oil-body protein fusion polypeptide and method for producing the same in algae
DE102017219800B4 (de) * 2017-11-08 2021-09-23 Helmholtz-Zentrum Dresden - Rossendorf E. V. Peptid-Trägermaterialien als biofunktionalisierte Sammler
WO2020187544A1 (en) 2019-03-19 2020-09-24 Unilever Plc Frozen confection
CN110776571B (zh) * 2019-11-04 2021-08-10 福建省中医药研究院(福建省青草药开发服务中心） 一种金属硫蛋白融合蛋白构建、固定化载体快速制备及其在重金属离子去除中的应用
EP4297580A1 (de) * 2021-02-26 2024-01-03 Société des Produits Nestlé S.A. Niedrig-ph-coextraktionsverfahren zur herstellung einer stabilen ölkörperlösung
CN112760316B (zh) * 2021-04-07 2021-08-24 中国科学院天津工业生物技术研究所 人工油体固定化多酶生产塔格糖的方法
CN113176362B (zh) * 2021-06-30 2021-11-19 中国农业科学院蜜蜂研究所 一种评估天然蜂花粉及发酵蜂花粉致敏性的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
US5650554A (en) * 1991-02-22 1997-07-22 Sembiosys Genetics Inc. Oil-body proteins as carriers of high-value peptides in plants
US5474925A (en) * 1991-12-19 1995-12-12 Agracetus, Inc. Immobilized proteins in cotton fiber
JP3639592B2 (ja) * 1992-04-15 2005-04-20 セムバイオシス ジェネティック インコーポレイテッド 植物中の高価値ペプチドの担体用の油体タンパク質
US5856452A (en) * 1996-12-16 1999-01-05 Sembiosys Genetics Inc. Oil bodies and associated proteins as affinity matrices

Also Published As

Publication number Publication date
AR010780A1 (es) 2000-07-12
CN1245503A (zh) 2000-02-23
EP1007554B1 (de) 2006-03-29
ES2259193T3 (es) 2006-09-16
KR100421935B1 (ko) 2004-03-10
IL130403A0 (en) 2000-06-01
DE69735599T2 (de) 2006-08-31
JP3833719B2 (ja) 2006-10-18
JP2001506241A (ja) 2001-05-15
US7332587B2 (en) 2008-02-19
US6924363B1 (en) 2005-08-02
US20030096320A1 (en) 2003-05-22
EP1007554A1 (de) 2000-06-14
BR9713727A (pt) 2000-01-25
ZA9711237B (en) 1998-07-06
US5856452A (en) 1999-01-05
HK1025977A1 (en) 2000-12-01
KR20000069499A (ko) 2000-11-25
NZ336558A (en) 2001-08-31
DE69735599D1 (de) 2006-05-18
CA2275489C (en) 2007-03-27
WO1998027115A1 (en) 1998-06-25
US20030059910A1 (en) 2003-03-27
CA2275489A1 (en) 1998-06-25
BR9713727B1 (pt) 2009-01-13
IL130403A (en) 2005-05-17
DK1007554T3 (da) 2006-05-01
TW589322B (en) 2004-06-01
AU739339B2 (en) 2001-10-11
CN1325513C (zh) 2007-07-11
JP2006306881A (ja) 2006-11-09
US6509453B1 (en) 2003-01-21
AU5220498A (en) 1998-07-15

Similar Documents

Publication Publication Date Title
ATE321777T1 (de) Ölkörper und damit assoziierte proteine als affinitätsmatrix
DE69411514D1 (de) Flugabwehrsystem und Flugabwehrkörper dafür
DE69732700D1 (de) Sphärisches elastomerlager
DE69422293D1 (de) Kugellager für schere und damit versehene schere
DE69838386D1 (de) Beleuchtungssystem und dessen anwendung
DE69827318D1 (de) Kombinierte, von aussen mit Druck beaufschlagte Gas-magnetische Lagervorrichtung und damit ausgestattete Spindeleinrichtung
DE69818465D1 (de) Dämpfer und ventil
EP0796643A4 (de) Spielvorrichtung und system damit
DE69637170D1 (de) Zonenbasierte güterordnung und steuersystem
DE69629987D1 (de) Funktelefone und Betriebsverfahren
DE69401389D1 (de) Kugelförmiges Lager und Montageverfahren
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
DE69714451D1 (de) Prionbindende proteine und deren verwendungen
DE59505427D1 (de) Lagerbuchse
DE19681612T1 (de) Selbstschmierender und selbstausrichtender Kolbenring
ATE233569T1 (de) Verwendung von proteine als mittel gegen autoimmunekrankheiten
DE69526203D1 (de) Biologische zielgerichtete mittel
EP1018551A4 (de) Megsin-protein
DE59701864D1 (de) Dämpferventilanordnung
EP1038958A4 (de) Menschliches nap1-protein
DE19709191B4 (de) Optischer Isolator und Verstärker
AU5777696A (en) Candida heat shock protein, cdna and uses thereof
DE69528261D1 (de) Benzopyrane und deren verwendung als therapeutische mittel
NO951197L (no) Integrert freserör og lagersammenstilling
DE69725834D1 (de) Focalebenenmatrix und Ansteuerungsverfahren davon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007554

Country of ref document: EP